Canada has lost its measles elimination status after nearly three decades, following a year-long outbreak that the Pan American Health Organization (PAHO) confirmed on Monday. The setback also affects the Americas region, which now loses its measles-free designation.
According to PAHO Director Dr. Jarbas Barbosa, the loss is “reversible” but serves as a warning to strengthen public health efforts. Canada has reported over 5,000 measles cases across nine provinces and one northern territory, with under-vaccinated communities driving the prolonged transmission.
Health experts say the resurgence of measles highlights serious lapses in vaccination outreach and growing vaccine hesitancy since the COVID-19 pandemic. Dr. Isaac Bogoch, an infectious disease specialist at Toronto General Hospital, described the situation as “a wake-up call” for Canada to improve accessibility and trust in immunization programs.
To maintain herd immunity, a 95% vaccination rate is required, as the measles vaccine is 97% effective after two doses. However, declining vaccination rates have allowed the virus to spread more easily, posing severe risks to children and vulnerable populations.
The Public Health Agency of Canada stated that while the spread has slowed, the outbreak persisted for over 12 months. The agency pledged to boost vaccination coverage, strengthen surveillance systems, and improve data sharing nationwide.
In Alberta, one of the hardest-hit provinces, cases have dropped by over 90% from their peak, with vaccination rates up 50% since March. Despite these gains, experts warn that losing measles elimination status is “a step backward,” symbolizing a return to preventable disease risks.
Other countries in the Americas, including the United States, Mexico, and Brazil, are also facing outbreaks as global vaccination rates decline—a concerning trend that could reverse decades of public health progress.


US Waives Iran Sanctions for 60 Days as Peace Talks Advance and Lebanon Sees Calm
Trump Administration Closes Delta Air Lines Investigation Over 2024 CrowdStrike Outage
U.S. Launches Trade Investigation Into Germany’s Pharmaceutical Cost-Cutting Plans
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
US Appeals Court Allows Trump Military Enlistment Ban on Transgender Recruits, Protects Current Service Members
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
US Expands Iran Sanctions, Targets Major Crypto Exchanges and Individuals
SEC Tokenized Stock Approval Still Expected as Regulatory Framework Advances
US Sanctions Cuban President Miguel Diaz-Canel and Key Officials Amid Rising Tensions
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
US Urges Europe to Impose Ebola Travel Restrictions Ahead of FIFA World Cup 2026
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Trump Forced Labour Tariff Plan Faces Criticism as Experts Question Effectiveness 



